Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea · Delayed Price · Currency is KRW 17,950
-450 (-2.45%)
At close: Apr 2, 2026
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 225.54 billion as of April 1, 2026. Its market cap has increased by 2.05% in one year.
Market Cap
225.54B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
10.65
Stock Price
17,950.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 225.54B, an increase of 674.54%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 225.54B | -6.84% |
| Dec 30, 2025 | 242.09B | 9.24% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 247.72B |
| Chong Kun Dang Holdings | 237.31B |
| HLB Pharmaceutical | 234.23B |
| Daewon Pharmaceutical | 225.48B |
| Ilyang Pharmaceutical Co.,Ltd | 217.97B |
| AptaBio Therapeutics | 212.11B |
| Samil Pharmaceutical Co.,Ltd | 208.05B |
| Suheung | 208.02B |